Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,963.00
Ask: 1,965.00
Change: -36.00 (-1.81%)
Spread: 2.00 (0.102%)
Open: 2,004.00
High: 2,004.00
Low: 1,958.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: N Brown jumps after broker upgrade

Wed, 21st Aug 2013 14:36

Internet shopping group N Brown was a high riser today after Credit Suisse raised its rating for the stock from 'neutral' to 'outperform' and lifted its target price from 455p to 620p.N Brown, whose brands include Simply Be, Jacamo and Figleaves, has seen its stock surge by around 50% so far this year but Credit Suisse still sees more upside given its potential to "transform this traditional credit-driven mail order business into a more competitive and profitable apparel company with scalability overseas".JPMorgan Indian Investment Trust was a heavy faller today as the rupee weakened to a fresh record low against the dollar on expectations that the Federal Reserve will soon begin to taper stimulus, as well as concerns over Indian growth.The outflow of funds from emerging markets was also putting downwards pressure on investment manager Ashmore Group,Man Group and Schroder Asia Pacific Fund.Hikma Pharmaceuticals trimmed gains slightly but was still trading in positive territory after raising its guidance to around 20% revenue growth for the year, from 17% previously, after a strong first half.African Barrick Gold declined after revealing that its CEO Greg Hawkins has resigned with immediate effect to "pursue other opportunities". He will be replaced by industry veteran Bradley Gordon, the former frontman of Intrepid Mines.Shares in sector peer Hochschild Mining also fell after the precious metals producer suspended its interim dividend as first-half results were hit by falling commodity prices.FTSE 250 - RisersBrown (N.) Group (BWNG) 567.00p +5.29%Howden Joinery Group (HWDN) 282.60p +3.74%Paragon Group Of Companies (PAG) 331.50p +3.43%Fisher (James) & Sons (FSJ) 1,092.00p +3.31%Enterprise Inns (ETI) 136.30p +2.64%Balfour Beatty (BBY) 252.30p +2.39%Drax Group (DRX) 674.50p +2.27%Senior (SNR) 280.60p +2.04%Afren (AFR) 144.20p +1.98%Ocado Group (OCDO) 282.40p +1.95%FTSE 250 - FallersJPMorgan Indian Inv Trust (JII) 288.00p -4.32%Imagination Technologies Group (IMG) 270.60p -4.25%Man Group (EMG) 81.45p -2.75%Alent (ALNT) 337.30p -2.51%Ashmore Group (ASHM) 327.20p -2.44%PayPoint (PAY) 1,083.00p -2.34%Catlin Group Ltd. (CGL) 463.10p -2.03%Kentz Corporation Ltd. (KENZ) 573.50p -1.97%Salamander Energy (SMDR) 121.70p -1.85%Schroder Asia Pacific Fund (SDP) 234.60p -1.84%BC
More News
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.